Maybe our application of Antisense technology is just a flop? I know in the US, a few firms are having success with it, but ANP seems to be on some kind of never-ending cooks-tour to what exactly? Time is $$$$$$$ and the clock's sure been ticking....and ticking.......
Who are the major holders in ANP? Do they still express confidence?
I accept in biotech things sure DO take time....but I think we've all be patient here....years and years....and years roll by and we're always talking about "the big announcement"......to what exactly??? Some mid-stage trial....that never seems to get underway!
A better and NEW road-map to commercial success please management OR, and one likely requires another....we need NEW directors and management!
Are our drug candidates simply not up to it?
Ann: ATL1103/atesidorsen Early Access Program - Update, page-28
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |